Migdal Insurance & Financial Holdings’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Migdal Insurance & Financial Holdings's NVS Position: Q3 2022 in Review
Migdal Insurance & Financial Holdings sold out of Novartis (NVS) in Q3 2022, closing a stake of 110 shares — an estimated $9K sold.
Migdal Insurance & Financial Holdings first reported a position in NVS in Q4 2016 and held it in 23 quarters. The position peaked at $34K in Q1 2017. 1,089 funds tracked by Wall St. Rank hold NVS as of Q3 2022.
- Migdal Insurance & Financial Holdings reported no remaining Novartis position as of Q3 2022 after selling out during the quarter.
- Migdal Insurance & Financial Holdings sold 110 Novartis shares in Q3 2022, an estimated $9K.
- Migdal Insurance & Financial Holdings first reported a position in Novartis in Q4 2016 and held it in 23 quarters.
- Migdal Insurance & Financial Holdings's Novartis position peaked at $34K in Q1 2017.
- 1,089 funds tracked by Wall St. Rank held Novartis as of Q3 2022.
Based on Migdal Insurance & Financial Holdings's 13F filing for Q3 2022, filed 31 Oct 2022.